主管单位:中华人民共和国
国家卫生健康委员会
总编辑:杨秋
编辑部主任:吴翔宇
邮发代号:80-528
定价:28.00元
全年:336.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)
英文作者:Wang Ziyuan Yan Junqiang
英文单位:Department of Neurology the First Affiliated Hospital of Henan University of Science & Technology Luoyang 471003 China
英文关键词:Parkinson′sdisease;Sleepdisorder;Apomorphine;Dopaminereceptor
帕金森病常伴随严重的睡眠障碍,严重影响患者生活质量。阿扑吗啡是一种多巴胺受体激动剂,在帕金森病的治疗中展现出良好的前景。现有研究表明,阿扑吗啡能够有效调节多巴胺功能,从而改善睡眠结构紊乱及昼夜节律失调等问题。然而,目前对其具体作用机制及临床应用的系统性研究仍较为有限。本文旨在综述阿扑吗啡在帕金森病睡眠障碍中的应用进展,探讨其作用机制、临床研究结果以及未来的研究方向,以期为临床实践提供参考。
Parkinson′s disease is often accompanied by severe sleep disorders, which seriously affect the quality of life of patients. Apopmorphine is a dopamine receptor agonist and shows good prospects in the treatment of Parkinson′s disease. Existing studies have shown that apopmorphine can effectively regulate dopamine function, thereby improving problems such as sleep structure disorders and circadian rhythm imbalances. However, at present, systematic research on its specific mechanism of action and clinical application is still relatively limited. This article aims to review the application progress of apopmorphine in sleep disorders of Parkinson′s disease, explore its mechanism of action, clinical research results and future research directions, with the expectation of providing references for clinical practice.
copyright 《中国医药》杂志编辑部
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址:www.chinamedicinej.com 京ICP备2020043099号-3
当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。